Science

Moderna reports promising findings for next-generation COVID vaccine The new version offers longer shelf-life advantages and paves the way for a flu-COVID combo vaccine. CIDRAP

...

The mRNA-1283 vaccine showed a higher immune response—including in seniors—than its currently licensed vaccine, called mRNA-1273.222. Response was higher against Omicron BA.4/BA.5 as well as the original SARS-CoV-2 virus.

...

...

FDA settles lawsuit over ivermectin content that doctors claimed harmed their practice | CNN The US Food and Drug Administration has settled a lawsuit over some of its posts about ivermectin, including what may have been one of its more popular pandemic-era social media campaigns. Jen Christensen CNN

The FDA said in an email to CNN on Wednesday that it “has chosen to resolve this lawsuit rather than continuing to litigate over statements that are between two and nearly four years old.”

Mpox cases in the US are on the rise as vaccination rates lag and new threats loom | CNN Mpox cases in the United States are twice as high as they were at this time last year, and experts are stressing the importance of improving vaccination coverage as transmission risks rise. Deidre McPhillips CNN

...

Transmission rates are still far below levels from 2022, when there were tens of thousands of cases in the US. But after a quieter year last year, experts say the US is vulnerable to increases in spread in a number of ways.

...